Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have signed a consent form, including agreeing to have a stored tumour tissue sample tested
- People who have a confirmed diagnosis of urothelial bladder cancer, at one of three stages: non-muscle-invasive (NMIBC), muscle-invasive (MIBC), or metastatic (mBC)
- People with non-muscle-invasive bladder cancer (NMIBC) who had a surgical procedure to remove bladder tumours (called a TURBT) at least 1 month but no more than 12 months before joining the study, and whose cancer has at least one high-risk feature, such as: a T1 tumour, a high-grade or G3 tumour, carcinoma in situ (CIS), or tumours that are multiple, recurring, and large (largest tumour 3 cm or more — all three of these conditions must apply together)
- People with muscle-invasive bladder cancer (MIBC) who had their bladder removed (cystectomy) at least 2 months but no more than 12 months before joining the study
- People with metastatic bladder cancer (mBC) whose metastatic diagnosis was made within the 12 months before joining the study
- People whose medical history records are available for review
- People for whom a stored tumour tissue sample (taken during a previous biopsy or surgery) is available
Who may not be able to join:
- People who have taken part in any other interventional clinical trial since their urothelial bladder cancer was diagnosed
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients receiving any intravesical treatment among patients with high-risk NMIBC; Proportion of patients receiving intravesical chemotherapy among patients with high-risk NMIBC; Proportion of patients receiving intravesical BCG treatment among patients with high-risk NMIBC; Proportion of patients receiving any intravesical treatment among patients with non-high-risk NMIBC; Proportion of patients receiving intravesical chemotherapy among patients with non-high-risk anamnestic NMIBC; Proportion of patients receiving intravesical BCG treatment among patients with non high-risk anam...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.